Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

w5Up4bucxqDhu7YwVeG6p+G6p+G7iuG7luG6teG6rDzhuq0wI+G7lsOUdyhVxqDhuqVVxqAx4buo4bqtxqDhuq0p4bqpYeG7tsagQDw64bqpxqDhuq3huqV9xqDhu5l44bq+4bul4buVLeG7nFTGoEBY4bqpxqDhuq08JjLGoEBl4bqx4bu2xqDhu7ZX4bq1xqDhurUpPeG6tcOVLynhu5zDlMOV4bq1xqDhu7YwVeG6p+G6p+G7iuG7luG6tcO5I1Xhu7jhu5bDlHcow5nhu4PGoOG7nOG7nC9RT8agdyhVxqBAxajGoOG7tikzxqDhuqVVxqAx4buo4bqtxqAwM+G7pDzGoOG6rSnhuqlh4bu2xqBAPDrhuqnGoOG6reG6pX3GoOG7tDsyKcag4bq/PCYxxqBAZeG6rzIoxqApOcagKVfhurXGoOG7tlfhurXGoOG7mXjhur7hu6Xhu5Ut4bucVMagQFjhuqnGoOG6rTwmMsagQGXhurHhu7bGoOG7tlfhurXGoOG6tSk94bq1xqDhur/EgzzGoOG6rSYyxqAoNjzGoMOt4bq/PCFV4bq/POG6pU/GoOG6reG6pTMyKMag4bu0YTzGoOG7tuG7pjIpxqDhuqdhxqDhu7ZVxqAx4buo4bu2xqDhu7Q7MinGoOG6t8agMmXEg+G7tsagMsOZ4buDxqBAxajGoOG6v2XhurHhuq3GoMOi4bqpw5rGoDFh4bu2xqBQ4bua4buaw5Phu5rhu5rhu5rGoDIoZeG6rzzDk8OVL+G6tcOUw5XhurXGoOG7tjBV4bqn4bqn4buK4buW4bq14buTM+G7uOG7g+G7lsOUw5U8MSjGoOG7tjBV4bqn4bqn4buK4buW4bu2MeG6py3hurUpM+G6rTPhu5bGoOG6rTzhuq0wI+G7iuG7lncoVcag4bqlVcagMeG7qOG6rcag4bqtKeG6qWHhu7bGoEA8OuG6qcag4bqt4bqlfcag4buZeOG6vuG7peG7lS3hu5xUxqBAWOG6qcag4bqtPCYyxqBAZeG6seG7tsag4bu2V+G6tcag4bq1KT3hurXGoCl7MinGoOG7pjIpxqDhu5zhu5bGoOG6p+G6peG7tuG7iuG7li8v4bu2w5Phu7gp4bu2MsOT4bq/Mi88MSgv4bu4I+G6pyDhuq0z4bq1L+G7uC3hu7RVM+G6rSlVMikpM1XDk+G6vzIvMiPhu4Hhuqcv4bui4bua4bui4bueL+G7nFJS4bu4UOG7mlJQUFDhu6Dhuq1SUOG7olIw4bucw5Phu4Ej4bu04bq14buWxqBVMOG6reG7iuG7lncoVcag4bqlVcagMeG7qOG6rcag4bqtKeG6qWHhu7bGoEA8OuG6qcag4bqt4bqlfcag4buZeOG6vuG7peG7lS3hu5xUxqBAWOG6qcag4bqtPCYyxqBAZeG6seG7tsag4bu2V+G6tcag4bq1KT3hurXhu5bGoOG7uFXhuq1VLeG6tSkz4bqtMy0z4bqlPCg8MlUwLeG6p+G6peG7tuG7iuG7linhuq3huq3hurXhuqdNLy/hu7bhu7gyPDEow5Phur88I+G6rTJVMeG6tTDhuqnhuqfDk+G6vzIv4bqtUeG7ouG7mi/huqnhurUwM1Xhu7gj4bu4L+G7tDMiMyBVL+G7ouG7muG7ouG7ml/hu5pRX+G7nOG7nC9V4bq/PCFV4bq/POG6pcOTIuG6tSjhu5bGoC/DlMOt4bq/PCFV4bq/POG6pcagQMWoxqBAZeG6seG7tsag4bu2KeG6qeG7gywyxqBAPzLGoOG7tsOa4bu2xqDhu7Q7MinGoOG6vzw7Msag4bq/w5nGoOG6tSk1MijGoCApw5oxxqDhuq3hu6Q8xqB3KFXDk8ag4buMxKkyKU3GoOG7kzAzMzHhu7Qj4bqlKOG7jsOVL+G6tcOUw5XhurXGoOG7tjBV4bqn4bqn4buK4buW4bq14buTM+G7uOG7g+G7lsOU4bqs4bqlMzIoxqAxw6Dhuq3GoOG6rSk5MijGoOG7tsOaM8ag4bu0w5ozxqDhu7YpPk/GoMOC4bqpacag4buXWOG6qcag4bqtZcag4bqt4bql4bq74bu2xqDhuq08P+G6tcagdyhVxqDhu4zhuqThu5Xhu6V14buOxqDhu7YpM8ag4bu0PD/huq3GoDA5xqDhuq0p4bqpYeG7tsagw63hur88IVXhur884bqlxqBAWOG6qcag4bqtPCYyxqBAxajGoEBl4bqx4bu2xqDhu7bhuqkyKMag4bu2V+G6tcag4bu2KTPGoOG7tsOa4bu2xqDhu7Q7MinGoOG6vzw7Msag4bq/w5nGoOG6tSk1MijGoCApw5oxxqDhuq3huqUmMsag4bqtM8OZMsagw6Lhuqlh4bu2w5PGoOG6pOG7leG7pXXGoDDDmcagQMOjMsag4bq/fcag4bu24bqpMijGoOG7tlfhurXGoCA8MinGoOG6tSk+xqDhu7YpM8agKTPhu6Thuq3GoEDDoDIoxqDhuq0p4bq9xqAyKCk8OzHGoOG6rSnhuqlh4bu2xqDhur/Dmcag4bu2NMagUOG7msSoxqDhu7bhuqHGoOG6tSlYMsag4bqt4bqlMzIoxqDhuq1Z4bq1xqBAM8OZMsag4buZKSMx4bqkVeG6pcagLcagMinDmcag4bqn4bumMsag4buH4bqpV+G6rcag4bqtKeG6qWHhu7bGoMOt4bq/PCFV4bq/POG6pcOTw5Uv4bq1w5TDleG6tcag4bu2MFXhuqfhuqfhu4rhu5bhurXhu5Mz4bu44buD4buWw5Thu5PDoMag4buCxqDhuq0/xqB3KFXGoEDFqMag4bu2V+G6tcag4bq1KT3hurXGoOG7tikzxqDhuq0p4bqpYeG7tsagw63hur88IVXhur884bqlxqDhuq0pIzPGoDHDoOG6rcagw6LhuqnDmsag4bqt4bqlezIpxqDhurUpJsag4bu2KeG6qcOdMsagQOG7sOG7tsag4bu0PDvhuq3GoEBl4bqx4bu2xqDhuq0p4bq74bu2xqApPDsyxqDhuq3huqUzMijGoOG6rSnhuq88xqAoPFUyxqAyKOG7qDLDk8ag4buZw5rhu7bGoCkz4buk4bqtxqBAw6AyKMag4bqtKeG6vcagMigpPDsxxqDhuq3hu6Q8xqB3KFXGoOG7uDwuMsag4bqlVcagMilVMinGoOG6v8OZxqDhu7Y0xqDDouG6qeG7g8agMTnGoDIpN8agKcOjMsag4bqnM8ag4bq/xIM8xqAyKTw64bqpxqDDouG6qWHhu7bGoCg8VcagICnDmuG7tk/GoOG6reG6pTMyKMag4bu0YTzGoOG7tuG7pjIpxqDhu7h94bu2Kcag4bu0OzIpxqBAVTIoxqAwVuG7g8agMFUyxqDhur/EgzzGoOG6rWHhu7bGoEDDoMagMilVMinDk8OVL+G6tcOUw5XhurXGoOG7tjBV4bqn4bqn4buK4buW4bq14buTM+G7uOG7g+G7lsOUw7nDoTzGoOG6reG6qVgyxqDhuq3huqVlxIPhu7ZPxqAyKGXhuq88xqBAw6kyKMagQFjhuqnGoOG6pOG7leG7pXXGoOG7rTzhuqU8MDDGoOG7lTE84bqt4bqlPCPhur/GoOG7tikzxqDhu7Q8P+G6rU/GoOG7mSkjMeG6pFXhuqXGoOG7tjTGoCA/xqApM+G7pOG7tinGoOG6p+G7pjLGoOG7h+G6qVfhuq3GoEBkxqDhuq0p4bqpYeG7tsagQCzGoEA8OuG6qcag4bqt4bqlfcag4bu2KTPGoCApM+G7pjIoxqBR4buaw5Phu5rhu5rhu5rGoDIoZeG6rzzGoDHhuqM8xqDhuq0pw5oyKMOTxqDhuqwpIzPGoDkyKMag4buVMTzhuq3huqU8I+G6v0/GoOG7tjTGoCnDozLGoOG7nOG7msagw6Lhuqlh4bu2xqAoPFXGoEDFqMagQDrGoDIoKX3GoDHhuqlVxqDhuq0p4bqpYeG7tsagw63hur88IVXhur884bqlxqDhu7ZkVcagdyhVw5PDlS/hurXDlMOV4bq1xqDhu7YwVeG6p+G6p+G7iuG7luG6teG7kzPhu7jhu4Phu5bDlOG6vsSDPMagKcOjMsagUOG7muG7msOT4bua4bua4buaxqDhuq3huqVl4bqvMijGoCnhurHhurVPxqB3KFXGoEBVMijGoOG7hz/hurXGoOG6rSnDqcag4buexqDhuq3huqUmMsag4bqtKT/GoCg8xIM8xqDhur86xqDhuqdhxqDhu7ZVxqAx4buo4bu2xqDhu7Q7MinGoOG7mXjhur7hu6Xhu5Ut4bucVMOTxqDhuqzhuqnhu4PGoDIpPCYyT8agMmXEg+G7tsagMsOZ4buDxqAxxIM8xqDhu7YpW8agKCk8xqAyKVkyxqApw6MyxqBRw5NQ4bua4buaxqDhu7ZVxqDhuq3hur3GoOG6vzMyKE/GoDHDoOG6rcag4bqtaMagMDvGoOG6rWXDozIoxqBAYTzGoOG6rSlX4bq1xqDhuqczxqDhur/EgzzGoDIpPDrhuqnGoMOi4bqpYeG7tsagKDxVxqAgKcOa4bu2w5PGoMO5PDsyxqAyKTw64bqpxqBAfVXGoOG6tSllw6MyKE/GoOG6reG6pTMyKMagQDTGoOG7tjTGoOG6rSlkxqBAOcagdjPhuqcg4bq/VU/GoEDFqMag4bu04buo4bqtxqBAWOG6qcag4bu44bqzxqDhu7Q3xqDhu7bDmuG7tsag4bu0PDsyxqDhurUpw5rhurXGoOG6tSkzMijGoOG6rTdVxqBAZeG6seG7tsagw5rhurXGoEDhu7Dhuq3GoEAsxqAgKWEyKMag4bu2KT/GoOG7uH3hu7YpxqDhu7Q7MinDky/Dk8OVL+G6tcOUw5XhurXGoOG7tjBV4bqn4bqn4buK4buW4bq1w63huqnhuq0pM+G6peG7lsOU4buM4bq+PCPhuq0yVTEr4buOw5Uv4bq1w5Q=

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh